[Table, End-of-life care].
Paul Roderick, Donal O’Donoghue(Centre Hospitalier Universitaire de Montpellier), Ikumi Okamoto(University of Southampton), Fliss EM Murtagh(King's College London), Geraldine Leydon(Broadmoor Hospital), Guiqing Yao(University of Leicester), Miriam Santer(NIHR Southampton Biomedical Research Centre), Hugh C. Rayner(Heartlands Hospital), Sarah Tonkin‐Crine(University of Southampton), Jonathan Klein(LabCorp (United States)), Roger Greenwood(Mount Sinai Beth Israel), Fiona Loud, Emma Murphy(King's College London), Fergus Caskey, Charles Tomson(Freeman Hospital), Robert Elias(University of San Francisco), Ken Farrington(University of Hertfordshire), Caroline Eyles(University of Southampton)
Unknown
April 1, 2015
Cited by 0
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Vascular access use in Europe and the United States: Results from the DOPPS
|Kidney International|2002|855
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2021|524
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2003|472